PLEASANTON, Calif., Nov. 7, 2013 (GLOBE NEWSWIRE) -- ZELTIQ®, (Nasdaq:ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it has priced an underwritten public offering of 4,500,000 shares of its common stock, all of which are being offered by selling stockholders, at a price to the public of $13.00 per share. The selling stockholders have also granted the underwriters a 30-day option to purchase up to 675,000 additional shares. Goldman Sachs & Co. and J.P. Morgan Securities LLC are acting as joint book-running managers for the offering, and Canaccord Genuity Inc. and William Blair & Company, L.L.C. are acting as co-managers for the offering.
Help employers find you! Check out all the jobs and post your resume.
